AUID Relative Valuation
AUID's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AUID is overvalued; if below, it's undervalued.
Historical Valuation
Authid Inc (AUID) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Authid Inc (AUID) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：1.05
Fair
0.00
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Authid Inc. (AUID) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Authid Inc. (AUID) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Authid Inc. (AUID) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Authid Inc. (AUID) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Authid Inc. (AUID) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Authid Inc (AUID) has a current Price-to-Book (P/B) ratio of 1.47. Compared to its 3-year average P/B ratio of 7.79 , the current P/B ratio is approximately -81.08% higher. Relative to its 5-year average P/B ratio of 13.78, the current P/B ratio is about -89.30% higher. Authid Inc (AUID) has a Forward Free Cash Flow (FCF) yield of approximately -101.44%. Compared to its 3-year average FCF yield of -33.12%, the current FCF yield is approximately 206.31% lower. Relative to its 5-year average FCF yield of -25.06% , the current FCF yield is about 304.76% lower.
1.47
P/B
Median3y
7.79
Median5y
13.78
-101.44
FCF Yield
Median3y
-33.12
Median5y
-25.06
Competitors Valuation Multiple
The average P/S ratio for AUID's competitors is 0.14, providing a benchmark for relative valuation. Authid Inc Corp (AUID) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of -142.64%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of AUID decreased by 85.02% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.33 to -0.64.
The secondary factor is the Margin Expansion, contributed -37.11%to the performance.
Overall, the performance of AUID in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
CLPR
Clipper Realty Inc
3.83USD
4.93%
INUV
Inuvo Inc
2.75USD
-0.72%
IMRX
Immuneering Corp
4.73USD
-43.22%
FORA
Forian Inc
2.12USD
-0.93%
RGC
Regencell Bioscience Holdings Ltd
41.42USD
-21.67%
BOTJ
Bank of the James
18.22USD
-0.27%
GBIO
Generation Bio Co
5.51USD
0.73%
OSTX
OS Therapies Inc
1.54USD
0.65%
NSTS
NSTS Bancorp Inc
12.74USD
-1.09%
Frequently Asked Questions
Is Authid Inc (AUID) currently overvalued or undervalued?
Authid Inc (AUID) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Authid Inc (AUID) is between to according to relative valuation methord.
What is Authid Inc (AUID) fair value?
AUID's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Authid Inc (AUID) is between to according to relative valuation methord.
How does AUID's valuation metrics compare to the industry average?
The average P/S ratio for AUID's competitors is 0.14, providing a benchmark for relative valuation. Authid Inc Corp (AUID) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -142.64%, this premium appears unsustainable.
What is the current P/B ratio for Authid Inc (AUID) as of Jan 09 2026?
As of Jan 09 2026, Authid Inc (AUID) has a P/B ratio of 1.47. This indicates that the market values AUID at 1.47 times its book value.
What is the current FCF Yield for Authid Inc (AUID) as of Jan 09 2026?
As of Jan 09 2026, Authid Inc (AUID) has a FCF Yield of -101.44%. This means that for every dollar of Authid Inc’s market capitalization, the company generates -101.44 cents in free cash flow.
What is the current Forward P/E ratio for Authid Inc (AUID) as of Jan 09 2026?
As of Jan 09 2026, Authid Inc (AUID) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Authid Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Authid Inc (AUID) as of Jan 09 2026?
As of Jan 09 2026, Authid Inc (AUID) has a Forward P/S ratio of 0.00. This means the market is valuing AUID at $0.00 for every dollar of expected revenue over the next 12 months.